FNY Managed Accounts’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
FNY Managed Accounts's PFE Position: Q3 2017 in Review
FNY Managed Accounts sold out of Pfizer (PFE) in Q3 2017, closing a stake of 479 shares — an estimated $15K sold.
FNY Managed Accounts first reported a position in PFE in Q1 2015 and held it in 3 quarters. The position peaked at $348K in Q1 2015. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- FNY Managed Accounts reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
- FNY Managed Accounts sold 479 Pfizer shares in Q3 2017, an estimated $15K.
- FNY Managed Accounts first reported a position in Pfizer in Q1 2015 and held it in 3 quarters.
- FNY Managed Accounts's Pfizer position peaked at $348K in Q1 2015.
- 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on FNY Managed Accounts's 13F filing for Q3 2017, filed 9 Nov 2017.